Casdin Capital’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-820,440
Closed -$16.7M 58
2021
Q1
$16.7M Hold
820,440
0.5% 35
2020
Q4
$21.8M Hold
820,440
0.65% 34
2020
Q3
$18.4M Buy
+820,440
New +$18.4M 0.82% 28